Sleep apnoea: is it time for new therapies?

Symposium
Chairs: R. Riha (Edinburgh (Edinburgh), United Kingdom), A. Simonds (London, United Kingdom)
Aims: to describe new treatment alternatives to continuous positive airway pressure. New pathophysiological phenotyping studies of upper airway function in obstructive sleep apnoea (OSA) have opened the way to new treatment strategies. This session will examine these new possibilities and thereby provide an overview on the current and future developments in the treatment of OSA.

The physiological phenotypes of OSA - the PALM scale approach D. Eckert (Randwick (NSW), Australia)
Can we use drugs to modulate upper airway function in OSA? L. Taranto Montemurro (Chestnut Hill , United States of America)
Hypoglossal nerve stimulation O. Vanderveken (Edegem (Antwerp), Belgium)
Mandibular advancement devices - short- and long-term effects M. Marklund (Umea, Sweden)